Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors

被引:18
作者
Cafolla, A
Dragoni, F
Girelli, G
Tosti, ME
Costante, A
De Luca, AM
Funaro, D
Scott, CS
机构
[1] Univ Roma La Sapienza, Dept Biotecnol Cellulari & Ematol, Rome, Italy
[2] Ist Super Sanita, Lab Epidemiol, I-00161 Rome, Italy
[3] Abbott Diagnost, Wiesbaden, Germany
关键词
Italian smoker-blood donors; red blood cell folate; serum folate; homocysteine; folic acid and vitamin C supplementation;
D O I
10.1016/S0021-9150(01)00745-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This trial Sought to examine the effects of high dosage of folic acid and vitamin C Supplementation on red blood cell folate (RCF), serum folate (SF) and homocysteine (Hey) levels in subjects who smoke more than 15 cigarettes per day. Methods: A prospective Study of 100 Italian repeat blood donors was undertaken to measure RCF, SF and Hey levels before and after 45 days of vitamin supplementation. All subjects were randomised into four groups: [A] folic acid (FA) 5 mg/day, [B] vitamin C 500 mg/day, [C] FA 5 mg/day Plus vitamin C 500 mg/day [D] no supplementation. Results: Before supplementation the median RCF, SF and Hey levels were similar in the four groups, 32 (40%) subjects had an RCF level below 340 nmol/l, 15 (18.8%) had an SF level below 6.8 nmol/l and 21 (26.3%) had an Hey level above 16 mumol/l. After 45 days the median RCF and SF levels were significantly (P<0.01) increased in all supplemented subjects. The median Hey level was significantly (P=0.008) reduced in subjects Supplemented with FA and significantly (P = 0.01) increased in those supplemented with vitamin C alone. Conclusion: The Supplementation with 5 FA mg/day is able to increase significantly both RCF and SF levels and reduce Hey level in Italian smoker-blood donors. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 24 条
[1]  
*BMPD, 1990, STAT SOFTW MAN
[2]  
Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894
[3]  
Cafolla A, 1998, EUR J HAEMATOL, V61, P160
[4]  
Cafolla A, 2000, HAEMATOLOGICA, V85, P694
[5]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[6]   Folate deficiencies and cardiovascular pathologies [J].
Durand, P ;
Prost, M ;
Blache, D .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (07) :419-429
[7]  
FIORE M, 1988, CLIN CHEM, V34, P1726
[8]   EFFECTS OF FOLATE IN CULTURE-MEDIUM ON COMMON FRAGILE SITES IN LYMPHOCYTE CHROMOSOMES FROM NORMAL AND LEUKEMIC CHILDREN [J].
GREEN, RJ ;
PHILLIPS, DL ;
CHEN, ATL ;
REIDY, JA ;
RAGAB, AH .
HUMAN GENETICS, 1988, 81 (01) :9-12
[9]   Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations [J].
Jacques, PF ;
Bostom, AG ;
Williams, RR ;
Ellison, RC ;
Eckfeldt, JH ;
Rosenberg, IH ;
Selhub, J ;
Rozen, R .
CIRCULATION, 1996, 93 (01) :7-9
[10]  
Lykkesfeldt J, 2000, AM J CLIN NUTR, V71, P530